Everything you need to file is on this page. If you have a deadline today, the fastest path is the direct contact below; my booking partner Athenas routes time-sensitive press requests to me within the working day.
The practical realities of deploying AI inside regulated industries — what works, what breaks, and why most enterprise AI rollouts underdeliver against their announcement.
Clinical AI in European healthcare specifically — documentation, decision support, hospital-network deployment under GDPR. I run a company doing this across major German hospital groups and across three countries.
Founder mode in the AI era — how the operating model of senior leaders is changing now that the technical, regulatory, and financial layers of a company are walkable for anyone willing to spend the time.
AI and self-improvement — how serious professionals are using AI as a reflective tool, what the patterns look like, what the risks are.
European competitiveness in applied AI — why regulatory complexity is closer to a training condition than a drag, and what the next decade of European AI talent will look like.
Comment in German, English, or French.
Everything below is ready to lift directly. Bios are written for copy-paste; photos and the Aiomics logo follow underneath. No form, no download barrier.
Dr. Sven Jungmann is a physician-founder and AI keynote speaker. He is the founding CEO of Aiomics, building clinical intelligence for European hospital networks. Previously Equity Partner and CMO at FoundersLane. Trained at Saarland, LSHTM, Oxford and Cambridge. Handelsblatt named him among Germany's 100 smartest innovators. Berlin.
Dr. Sven Jungmann is a physician-founder, investor, and one of Europe's working voices on AI in regulated industries. He is the founding CEO of Aiomics, which builds clinical intelligence for European hospital networks under GDPR and ordinary hospital data governance. Before Aiomics he was Equity Partner and Chief Medical Officer at FoundersLane (acquired by Creative Dock, 2022) and founded the medical-diagnostics company Halitus. He trained in medicine at Saarland, in public health at the London School of Hygiene & Tropical Medicine, in public policy at Oxford, and in entrepreneurship at the University of Cambridge. Handelsblatt named him to its list of Germany's 100 smartest innovators in 2017. He speaks in German, English, and French. Based in Berlin.
Dr. Sven Jungmann is a physician-founder, investor, and keynote speaker on AI in regulated industries. He is the founding CEO of Aiomics, which builds clinical intelligence for European hospital networks — software that keeps patient records correct as hospitals let AI take on more of the documentation load. At pre-seed stage Aiomics is already piloting across some of the largest hospital groups in three countries, with master service agreements on track to reach millions in ARR.
Before Aiomics he served as Equity Partner and Chief Medical Officer at FoundersLane, helping build it into one of Europe's larger corporate venture builders through its 2022 acquisition by Creative Dock. He was founder of the medical-diagnostics company Halitus (wound down in 2025) and a founding-team member of smart Helios, the first digital health venture inside the Helios/Fresenius hospital group. He advises Speedinvest and works with private equity and M&A firms on healthcare and AI mandates.
He trained in medicine at the University of Saarland, in public health at the London School of Hygiene & Tropical Medicine, in public policy at Oxford (MPP) and in entrepreneurship at the University of Cambridge (PG Dip). In 2017, Handelsblatt named him to its list of Germany's 100 smartest innovators — the "Big Data Doctor." He holds the Kounelakis-Zegarac-Pollock Prize from Oxford and a US$30,000 Rotary International scholarship. He speaks in German, English, and French. Based in Berlin.
Right-click → "Save image as" on any of these to use. High-resolution master files are available on request.
Founding CEO of Aiomics, building clinical intelligence for European hospital networks. Deployed across major German hospital groups; piloting in three countries at pre-seed stage.
Trained at Saarland (medicine), the London School of Hygiene & Tropical Medicine (MSc Public Health), the University of Oxford (MPP), and the University of Cambridge (PG Dip Entrepreneurship).
Previously Equity Partner and CMO at FoundersLane (acquired by Creative Dock, 2022). Founder of Halitus, a medical diagnostics company wound down in 2025. Founding-team member of smart Helios, the first digital health venture inside the Helios/Fresenius hospital group.
Advisor to Speedinvest and to private equity and M&A firms on healthcare and AI. Angel investor.
Recognition. Named to Handelsblatt's list of Germany's 100 smartest innovators in 2017 (the "Big Data Doctor"). Awarded the Kounelakis-Zegarac-Pollock Prize at Oxford. Recipient of a US$30,000 Rotary International scholarship.
Languages. German, English, French.
I'm happy to comment on AI in regulated industries, the operating realities of building a clinical AI company in Europe, and the broader argument I make on stage about the human work that surrounds AI use. I'm also happy to comment in German, English, or French.
I don't comment on specific Aiomics customers, on active commercial conversations, or on the internal affairs of organisations I advise. I avoid commentary on specific identifiable patients or clinical cases, and I avoid public commentary on competitor companies in the clinical-AI space.
I will not appear on panels or in formats that exist primarily to manufacture controversy. If you're not sure whether your format fits, ask — the answer is usually yes.
For speaker bookings, see Talks. For all other inquiries, see Contact.
